AKORA RESOURCES LIMITED — Director's Dealing 2023

Aug 1, 2023

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity AKORA Resources Limited

ABN 90 139 847 555

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Matthew Damian Gill
Date of appointment	2 August 2023

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of Securities interest Note: Provide details of the circumstances giving rise to the relevant interest. N/A N/A

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Letter of Appointment, dated 2 August 2023
Nature of interest	Remuneration is $50,000 per year (inclusive ofsuperannuation) and, subject to shareholdersperformance rights on completion ofmilestones
Name of registered holder(if issued securities)	MD Gill
No. and class of securities to whichinterest relates	Subject to shareholder approval 200,000performance rights at a fair value of $40,000

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002